3.6.5 Therapeutic agents and techniques for managing anaemia |
![]() |
|
|
Read through these techniques. Then have a look at the map at the foot of the page and see how they fit into the context of blood conservation.
Stop any bleeding
An obvious, but vital, step in blood conservation.
Oxygen support
During surgery the anaesthetist can change the method and amount of oxygen given to a patient. Normally a small amount of oxygen (1.5%) is carried in the plasma. The anaesthetist can use a ventilator to deliver higher concentrations in the plasma. In combination with other methods of oxygen delivery this can mean a blood transfusion is avoided.
Haemoglobin solutions (when available)
Crit
Care Med. 2003 Dec;31(12 Suppl):S698-707:
Hemoglobin solutions.
Creteur J, Vincent JL.
Department of
Intensive Care, Erasme
University
Hospital, Free University of Brussels, Belgium.
OBJECTIVE: To review current knowledge about cell-free hemoglobin solutions.
DATA SOURCE: A computerized MEDLINE search was used to retrieve all studies
concerning cell- free hemoglobin solutions from 1990 to 2003. The reference
lists of all available review articles and primary studies were also reviewed to
identify references not identified in the computerized search. STUDY SELECTION:
All clinical and experimental studies involving cell-free hemoglobin solutions
were included. DATA EXTRACTION: From the selected studies, information was
obtained regarding the experimental model or the study population in which
cell-free hemoglobin solutions were investigated, the type of cell-free
hemoglobin solution used, their deleterious or beneficial effects, and their
possible indications. DATA SYNTHESIS:In many studies,
hemoglobin solutions were considered as efficient resuscitative agents and good
alternatives to red blood cell transfusion, owing to their marked vasopressor
effect, coupled with their capacity to improve the microcirculation and rapidly
restore metabolic parameters. The main problems identified include excessive
systemic vasoconstriction and oxidative damage. Initial enthusiasm in
the development of hemoglobin solutions has been tempered recently by the
negative results of a
U.S. multicenter trial studying the early infusion of
diaspirin cross-linked hemoglobin in trauma patients. Nevertheless, the
properties of diaspirin cross- linked hemoglobin (and particularly the strong
vasopressor effects) cannot be attributed to all hemoglobin solutions, and
results of new clinical studies are eagerly awaited to evaluate the potential
benefit of such solutions in the management of trauma patients. CONCLUSIONS:
Today, we are aware of the effects of the first generation of blood substitutes.
Further research is ongoing into newer solutions. One area of interest is the
development of new molecular structures to decrease nitric oxide binding, thus
minimizing any adverse events and maximizing potential benefits. Nevertheless,
possible adverse effects need to be carefully evaluated before these agents can
be widely administered.
Perfluorcarbon-based oxygen-carriers (when available)
Intravenous fluids that have the ability to carry oxygen. Sometimes referred to as "oxygen-carrying blood substitutes." Currently being assessed in clinical trials. Perflubron is the generic name of one of the more versatile PFCs.
Maintain intravascular volume
The
human body needs the right proportions of water in 3 compartments:
1. in the interior of cells (intracellular)
2. in the interior of blood vessels (intravascular, in the plasma)
3. in the space between cells (interstitial, outside the blood vessels)
Intravascular volume can be maintained by
volume expanders
Haematinics
Agents that increase the amount of haemaglobin in the blood.
· Iron
A nutrient that is required by red blood cells for good oxygen-carrying capacity. Iron is important for bloodless surgery and can be obtained from dietary sources like red meat or through supplements, such as ferrous sulfate or ferrous gluconate.
· Folic acid
A member of the VitaminB complex
· Vitamin B12
Essential for the formation of red blood cells
Erythropoietin (rHuEPO)
Erythropoietin is the name of a chemical normally produced by the body, primarily by the kidneys. Erythropoietin stimulates the bone marrow to produce red blood cells. Laboratory-made synthetic erythropoietin (e.g., Procrit, Epoetin alfa, or Epogen) may be administered prior to a bloodless surgery procedure in order to maximize the bone marrow's production of red blood cells.
Nutritional support
Enteral tube nutrition may be used in patients with a functioning GI tract to supplement oral feeding or to replace it entirely
Parenteral nutrition is administered intravenously.
Immunosuppressive agents if indicated
A substance that suppresses or interferes with normal immune response. Used in controlling autoimmune diseases and in enhancing the chances for survival of foreign tissue grafts and transplants. A wide variety of drugs are used as immunosuppressive agents.
Hyperbaric oxygen therapy
Hyperbaric means to be at higher-than-normal atmospheric pressure. Hyperbaric oxygen therapy is used in some facilities to assist bloodless medicine in certain situations. The patient enters a chamber and breathes pressurized oxygen, which concentrates oxygen in the blood.
See The Healing Powers of Hyperbaric Oxygen Treatment
Tolerate lower degree of normovolemic anaemia (10/30 rule has no scientific basis)
Most patients can tolerate much lower haemoglobin levels as long as normal volume is maintained. The decision to transfuse a should be based, not on a single haemoglobin figure, but rather on clinical indicators unique to each patient.

![]() |